Form 4: Verrica Pharmaceuticals CEO Ted White Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Verrica Pharmaceuticals' CEO, Ted White, sold shares of common stock to cover statutory tax withholding obligations related to the settlement of restricted stock units.
Summary
- On July 22, 2024, Ted White, the President and CEO of Verrica Pharmaceuticals Inc., sold 32,469 shares of common stock at a weighted average price of $7.06.
- On July 23, 2024, White sold an additional 154 shares at $6.98.
- These sales were mandated by Verrica Pharmaceuticals' equity incentive plan to cover statutory tax withholding obligations.
- Following these transactions, White directly owns 249,967 shares of Verrica Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock sales for tax obligations, which is neither particularly positive nor negative. It's a neutral event.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CEO, trade their company's stock. These filings provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely minimal given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 07/22/2024 | Ted White sold 32,469 shares of common stock at a weighted average price of $7.06. |
| 07/23/2024 | Ted White sold 154 shares of common stock at $6.98. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.